biotech regeneron - Search News

News

Regeneron To Buy 23andMe For $256M

Pharmaceutical company Regeneron buying 23andMe for $256 million

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase Monday.

Ars Technica · 1d

Biotech company Regeneron to buy bankrupt 23andMe for $256M

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy-protection promises.

ABC News on MSN · 1d

Regeneron Pharmaceuticals to buy 23andMe for $256M

Regeneron Pharmaceuticals on Monday said it would buy genetic testing company 23andMe, which filed for bankruptcy in March following a series of setbacks.

MassDevice23h

Regeneron to acquire 23andMe for $256M, plans to continue consumer genetics services

Regeneron Pharmaceuticals is set to acquire substantially all assets of 23andMe for $256 million. The deal is expected to ...

1don MSN

Regeneron Pharmaceuticals to buy 23andMe for $256M — taking control of genetic data of millions

It will acquire genetic data of more than 15 million customers – raising privacy concerns from individuals who had willingly ...

Daily Voice on MSN1d

Westchester-Based Regeneron Buying Bankrupt 23andMe For $256M, Pledges To Protect DNA Data

Regeneron Pharmaceuticals will acquire embattled DNA testing company 23andMe in a $256 million court-supervised sale, ...

Pharmabiz7h

Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million

Regeneron Pharmaceuticals enters into asset purchase agreement to acquire 23andMe for $256 million: Tarrytown, New York Wednesday, May 21, 2025, 13:00 Hrs [IST] Regeneron Pharmace ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results